BioSpace News Archive

Pharm Country

ACGT Opens 2020 Cancer Cell & Gene Therapy Research Grant Program Focusing on Solid Tumors – Glioblastoma and Pancreatic Cancer

Alliance for Cancer Gene Therapy announced the availability of grants up to $500,000 each for the 2020 grant cycle.

November 17, 2019
·
3 min read
Alzheimer’s Research UK welcomes international research funding for UK study

The US-based charity Alzheimer’s Association announces a $7 million dollar grant to allow UCL researchers to carry out detailed assessments of individuals from the 1946 birth cohort.

November 17, 2019
·
1 min read
Drug Development

Consistent Effects of FARXIGA in Heart Failure Patients With Reduced Ejection Fraction Shown in New Analyses From Landmark Phase III DAPA-HF Trial

Data were consistent in patients with and without type 2 diabetes, showed early effects in the first month and improvement in patient-reported outcomes

November 17, 2019
·
10 min read
Business

Interim analysis from EMPRISE real-world study shows Jardiance® decreased risk of hospitalization for heart failure compared with DPP-4 inhibitors and GLP-1 receptor agonists

This analysis on effectiveness also shows Jardiance® (empagliflozin) was associated with a similar risk of non-fatal atherosclerotic cardiovascular events compared with DPP-4 inhibitors or GLP-1 receptor agonists

November 17, 2019
·
16 min read
Biotech Bay

Personalis, Inc. to Present New Data at the AACR Tumor Immunology and Immunotherapy Conference

Personalis, Inc. announced that the company will participate in the AACR Tumor Immunology and Immunotherapy conference at the Boston Marriott Copley Place in Boston, MA, November 17-20, including poster presentations on November 18th and 19th.

November 17, 2019
·
2 min read
BioCapital

Subgroup Analysis of TWILIGHT Trial Patients With Non-ST Elevation Acute Coronary Syndrome (NSTE-ACS) Who Underwent PCI Showed BRILINTA Monotherapy Reduced the Risk of Clinically Relevant Bleeding Compared With Dual Antiplatelet Therapy (DAPT)

Secondary endpoint of subgroup analysis showed similar rates of the composite of all-cause death, myocardial infarction or stroke between monotherapy and DAPT

November 17, 2019
·
9 min read
Business

3SBio Selects Verseau’s PSGL-1-targeted Antibody VTX-0811 as First Partnered Macrophage Checkpoint Modulator in Immuno-Oncology Collaboration

PSGL-1, a novel target for immunotherapy, can induce macrophage reprogramming and activate a coordinated anti-tumor inflammatory response

November 17, 2019
·
6 min read
Drug Development

Novartis PARAGON-HF analyses suggest Entresto® benefit beyond HFrEF

Entresto (sacubitril/valsartan) demonstrated greatest benefit in HFpEF patients with ejection fractions adjacent to HFrEF, compared to valsartan

November 17, 2019
·
17 min read
Drug Development

Karuna Therapeutics Schedules Webcast and Conference Call to Announce Results from its Phase 2 Clinical Trial of KarXT for the Treatment of Psychosis in Patients with Schizophrenia

Karuna Therapeutics, Inc. announced it will hold a webcast and conference call on Monday, November 18, 2019 at 8:30 a.m. EST to provide results from its Phase 2 clinical trial of KarXT for the treatment of acute psychosis in patients with schizophrenia.

November 17, 2019
·
1 min read
Business

AVITA Medical Names David McIntyre as Chief Financial Officer

Appointment Enhances Executive Leadership Team as AVITA Medical Broadens Access to Investors and Continues Growth Trajectory

November 17, 2019
·
6 min read